EP 1506187 A1 20050216 - 2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS
Title (en)
2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS
Title (de)
2-THIO-SUBSTITUIERTE IMIDAZOLDERIVATE UND IHRE VERWENDUNG IN DER PHARMAZIE
Title (fr)
DERIVES IMIDAZOLE A SUBSTITUTION 2-THIO ET UTILISATION EN PHARMACIE
Publication
Application
Priority
- DE 10222103 A 20020517
- EP 0305172 W 20030516
Abstract (en)
[origin: WO03097633A1] The invention relates to 2-thio-substituted imidazole derivatives of formula (I), wherein radicals R1, R2, R3, R4 and p have the meanings as cited in the description. The inventive compounds comprise an immunomodulating effect and/or an action that inhibits the release of cytokine, and are thus suited for treating diseases associated with a disorder of the immune system.
IPC 1-7
C07D 401/04; C07D 405/14; C07D 401/14; A61K 31/4164; A61P 37/02
IPC 8 full level
A61K 31/4439 (2006.01); A61K 31/4545 (2006.01); A61K 31/5377 (2006.01); A61P 1/00 (2006.01); A61P 1/02 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 1/18 (2006.01); A61P 3/10 (2006.01); A61P 7/00 (2006.01); A61P 9/04 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 17/14 (2006.01); A61P 19/02 (2006.01); A61P 19/06 (2006.01); A61P 19/10 (2006.01); A61P 25/00 (2006.01); A61P 25/04 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); A61P 43/00 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01)
CPC (source: EP US)
A61P 1/00 (2017.12 - EP); A61P 1/02 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 1/18 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 17/14 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/06 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/18 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 401/04 (2013.01 - EP US); C07D 401/14 (2013.01 - EP US); C07D 405/14 (2013.01 - EP US)
Citation (search report)
See references of WO 03097633A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03097633 A1 20031127; WO 03097633 A8 20040401; AU 2003236665 A1 20031202; DE 10222103 A1 20031127; EP 1506187 A1 20050216; JP 2005530799 A 20051013; US 2006252810 A1 20061109; US 7442713 B2 20081028
DOCDB simple family (application)
EP 0305172 W 20030516; AU 2003236665 A 20030516; DE 10222103 A 20020517; EP 03735405 A 20030516; JP 2004505366 A 20030516; US 51491105 A 20050510